promotion image of download ymail app
Promoted
Orla
Lv 4
Orla asked in Business & FinanceInvesting · 2 months ago

That malaria drug hydroxychloroquine which trump is pushing as a corona "game changer," doesn't trump happen to own stock in that company?

5 Answers

Relevance
  • 2 months ago
    Favorite Answer

    He does, but the amount of stock he has in it is small enough that a rational person would expect it not to influence his judgment.  

    Of course, that's assuming he's telling the truth in his financial disclosure.  And that he's a rational person.

    • ♥Sweetness♥
      Lv 7
      2 months agoReport

      Internet high five fren, you nailed this one.

    • Commenter avatarLogin to reply the answers
  • Anonymous
    2 months ago

    If he does, its a tiny amount. Not meaningful for an orange billionaire. Plus, the drug is generic. No big profits.

    • Commenter avatarLogin to reply the answers
  • 2 months ago

    Probably, but from what I am reading, it really isn't doing a good job. It isn't helping the sickest patients who need a strong drug.

    • Commenter avatarLogin to reply the answers
  • y
    Lv 7
    2 months ago

    One of the companies that sells/manufactures it. Probably owns stock in other drug companies, as well as shipping, manufacturing, and dozens more. That particular drug is easily made, has or is being made in more then a dozens places for a handful of different companies. I think it is actually the one that Trump owns stock in that offered the process for free, to any manufacture that wanted it at this time, to help out. All that really matters is that is is readily available, cheap, and easily made, and effective. As a china, two European short studies have concluded as well as what 1000's of doc in the US have said about it's effectiveness. If it works, who cares who owns what

    • Commenter avatarLogin to reply the answers
  • How do you think about the answers? You can sign in to vote the answer.
  • 2 months ago

    He does, but it's ridiculously little. 

    Forbes estimates the value of Trump’s Sanofi (a French manufacturer of Plaquenil, a brand-name version of the drug) holdings to be less than $3,000; for context, Forbes estimates Trump's total net worth at $2.1 billion.

    A Sanofi spokesperson said that the company no longer sells or distributes Plaquenil in the U.S., but does sell the drug internationally.

    Source: Forbes

    • Commenter avatarLogin to reply the answers
Still have questions? Get your answers by asking now.